SecBot SecBot
144 ·Filed Jun 30, 2026

QURE

uniQure N.V.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001973379-26-000260
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for subsequent Form 4 filings to confirm execution; the 10b5-1 plan reduces signaling value. No immediate trading catalyst from this filing alone.

DirectionNeutral
Confidencemedium
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$45.17
T+0 close · Jun 30, 2026 · via day close
Latest settled
−11.29%
T+20 · $40.07
Vs SPY
−9.11%
α at T+20
Next horizon
T+60
due 8w ago
  1. T+0 · Jul 1 $45.17entry
  2. T+1 · 5mo ago −7.44%α −7.31% · $41.81
  3. T+5 · 4mo ago −8.32%α −8.59% · $41.41
  4. T+20 · 4mo ago −11.29%α −9.11% · $40.07
  5. T+60 · due 8w ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Jack Kaye filed a Form 144 to sell 21,167 ordinary shares (~$983K) as part of a pre-existing 10b5-1 plan adopted in June 2025. The sale is routine and represents a small fraction of the company's $3.0B market cap, with no material signaling value.

Key Facts

  • Director Jack Kaye filed Form 144 to sell 21,167 ordinary shares.
  • Estimated market value of proposed sale: $983,032.57.
  • Sale is pursuant to a 10b5-1 trading plan adopted June 16, 2025.
  • Prior sales by same insider in June 2026: 2,645 shares (06/03), 1,993 shares (06/11), 5,295 shares (06/17).
  • Proposed sale represents ~0.033% of market cap.

Financial Impact

Proposed sale of ~$983K, small relative to $3.0B market cap.

dilution

Risk Factors

  • Insider selling could accelerate if plan is modified, but current plan is pre-scheduled.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001973379-26-000260
Document: 0001973379-26-000260-index.html0001973379-26-000260
Document: 0001973379-26-000260.txt0001973379-26-000260

Track record

38 reports on QURE

Performance horizon

6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +27.15% at T+20 after the Jul 29, 2026 report. 8 of 11 went positive at some point.

Filters
  1. Nov 6, 202610d ago 144 Neutral 2/10 Entry $22.79 to $22.71 Now $21.88 −3.99% ▼ −0.35% +0.02% vs SPY
  2. Nov 4, 202612d ago 8-K Bullish 7/10 No price data
  3. Nov 4, 202612d ago Press Release Neutral 6/10 Entry $23.03 to $21.01 Now $21.88 −4.99% ▼ −8.77% −4.36% vs SPY
  4. Nov 2, 202614d ago 8-K Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
  5. Nov 2, 202614d ago Press Release Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
  6. Oct 16, 20264w ago SC 13G/A Neutral 3/10 Entry $21.78 to $22.20 Now $21.88 +0.46% ▲ +1.93% +1.51% vs SPY
  7. Sep 2, 202610w ago 8-K Bullish 7/10 Entry $46.23 to $44.86 Now $21.88 −52.67% ▼ −2.96% −4.01% vs SPY
  8. Jul 29, 202615w ago 8-K Bullish 8/10 Entry $40.07 to $42.19 Now $21.88 −45.40% ▲ +5.29% +3.61% vs SPY
  9. Jul 7, 202619w ago Insider Cluster Bearish 5/10 Entry $41.41 to $43.49 Now $21.88 +47.16% ▼ −5.02% −5.33% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Bearish 4/10 Entry $41.81 to $41.36 Now $21.88 +47.67% ▲ +1.08% +1.95% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens in 9h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026